NCT00417066View on ClinicalTrials.gov

Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders

PHASE4CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

July 31, 2006

Conditions
InfertilityPremature Ovarian Failure
Interventions
DRUG

Ganirelix 0.25mg (Orgalutran, Organon, The Netherlands)

DRUG

Arvekap 0.1mg (Triptorelin, Ipsen, France)

Trial Locations (1)

11528

Eugonia, Athens

All Listed Sponsors
lead

Eugonia

OTHER

NCT00417066 - Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders | Biotech Hunter | Biotech Hunter